TY - JOUR T1 - Limits and opportunities of SARS-CoV-2 antigen rapid tests – an experience based perspective JF - medRxiv DO - 10.1101/2020.09.22.20199372 SP - 2020.09.22.20199372 AU - Jessica Lüsebrink AU - Oliver Schildgen AU - Verena Schildgen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/22/2020.09.22.20199372.abstract N2 - Due to the currently increasing case numbers of SARS-CoV-2 infections worldwide there is an increasing need for rapid diagnostic devices in addition to existing PCR-capacities. Therefore, rapid antigen assays including lateral flow assays are discussed as an alternative method. In comparison to an established RT-PCR protocol, however the novel lateral flow assay unfortunately lowered the expectations set in these assays.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Funding was available for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Vote 122/2016 Ethical Committee of the Private University of Witten/HerdeckeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are included in the manuscript. ER -